164 related articles for article (PubMed ID: 30804001)
1. Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K
McLeod RL; Gil MA; Chen D; Cabal A; Katz J; Methot J; Woodhouse JD; Dorosh L; Geda P; Mehta K; Cicmil M; Baltus GA; Bass A; Houshyar H; Caniga M; Yu H; Gervais F; Alves S; Shah S
J Pharmacol Exp Ther; 2019 May; 369(2):223-233. PubMed ID: 30804001
[TBL] [Abstract][Full Text] [Related]
2. Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase
Begg M; Edwards CD; Hamblin JN; Pefani E; Wilson R; Gilbert J; Vitulli G; Mallett D; Morrell J; Hingle MI; Uddin S; Ehtesham F; Marotti M; Harrell A; Newman CF; Fernando D; Clark J; Cahn A; Hessel EM
J Pharmacol Exp Ther; 2019 Jun; 369(3):443-453. PubMed ID: 30940692
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib.
Begg M; Wilson R; Hamblin JN; Montembault M; Green J; Deans A; Amour A; Worsley S; Fantom K; Cui Y; Dear G; Ahmad S; Kielkowska A; Clark J; Boyce M; Cahn A; Hessel EM
J Pharmacol Exp Ther; 2019 Jun; 369(3):337-344. PubMed ID: 30886125
[TBL] [Abstract][Full Text] [Related]
4. Structurally novel PI3Kδ/γ dual inhibitors characterized by a seven-membered spirocyclic spacer: The SARs investigation and PK evaluation.
Tao Q; Chen Y; Liang X; Hu Y; Li J; Fang F; Wang H; Meng C; Liang J; Ma X; Gui S
Eur J Med Chem; 2020 Apr; 191():112143. PubMed ID: 32078865
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.
Down K; Amour A; Baldwin IR; Cooper AW; Deakin AM; Felton LM; Guntrip SB; Hardy C; Harrison ZA; Jones KL; Jones P; Keeling SE; Le J; Livia S; Lucas F; Lunniss CJ; Parr NJ; Robinson E; Rowland P; Smith S; Thomas DA; Vitulli G; Washio Y; Hamblin JN
J Med Chem; 2015 Sep; 58(18):7381-99. PubMed ID: 26301626
[TBL] [Abstract][Full Text] [Related]
6. Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase
Shin N; Stubbs M; Koblish H; Yue EW; Soloviev M; Douty B; Wang KH; Wang Q; Gao M; Feldman P; Yang G; Hall L; Hansbury M; O'Connor S; Leffet L; Collins R; Katiyar K; He X; Waeltz P; Collier P; Lu J; Li YL; Li Y; Liu PCC; Burn T; Covington M; Diamond S; Shuey D; Roberts A; Yeleswaram S; Hollis G; Metcalf B; Yao W; Huber R; Combs A; Newton R; Scherle P
J Pharmacol Exp Ther; 2020 Jul; 374(1):211-222. PubMed ID: 32345620
[TBL] [Abstract][Full Text] [Related]
7. Flavonoids as Th1/Th2 cytokines immunomodulators: A systematic review of studies on animal models.
Gandhi GR; Neta MTSL; Sathiyabama RG; Quintans JSS; de Oliveira E Silva AM; Araújo AAS; Narain N; Júnior LJQ; Gurgel RQ
Phytomedicine; 2018 May; 44():74-84. PubMed ID: 29895495
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation.
Gil MA; Caniga M; Woodhouse JD; Eckman J; Lee HH; Salmon M; Naber J; Hamilton VT; Sevilla RS; Bettano K; Klappenbach J; Moy L; Correll CC; Gervais FG; Siliphaivanh P; Zhang W; Zhang-Hoover J; McLeod RL; Cicmil M
Eur J Pharmacol; 2014 Nov; 743():106-16. PubMed ID: 25261040
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target.
Henley ZA; Amour A; Barton N; Bantscheff M; Bergamini G; Bertrand SM; Convery M; Down K; Dümpelfeld B; Edwards CD; Grandi P; Gore PM; Keeling S; Livia S; Mallett D; Maxwell A; Price M; Rau C; Reinhard FBM; Rowedder J; Rowland P; Taylor JA; Thomas DA; Hessel EM; Hamblin JN
J Med Chem; 2020 Jan; 63(2):638-655. PubMed ID: 31855425
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720.
Sawicka E; Zuany-Amorim C; Manlius C; Trifilieff A; Brinkmann V; Kemeny DM; Walker C
J Immunol; 2003 Dec; 171(11):6206-14. PubMed ID: 14634137
[TBL] [Abstract][Full Text] [Related]
11. Bioisosteric replacements of the indole moiety for the development of a potent and selective PI3Kδ inhibitor: Design, synthesis and biological evaluation.
Yang C; Xu C; Li Z; Chen Y; Wu T; Hong H; Lu M; Jia Y; Yang Y; Liu X; Deng M; Chen Z; Li Q; Ling Y; Zhou Y
Eur J Med Chem; 2021 Nov; 223():113661. PubMed ID: 34237636
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-inflammatory effects of PI3Kδ/γ inhibitors for treating acute lung injury.
Xiong W; Jia L; Cai Y; Chen Y; Gao M; Jin J; Zhu J
Immunobiology; 2023 Nov; 228(6):152753. PubMed ID: 37832501
[TBL] [Abstract][Full Text] [Related]
13. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma.
Huang TJ; MacAry PA; Eynott P; Moussavi A; Daniel KC; Askenase PW; Kemeny DM; Chung KF
J Immunol; 2001 Jan; 166(1):207-17. PubMed ID: 11123294
[TBL] [Abstract][Full Text] [Related]
14. Free-Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of
Barnes L; Blaber H; Brooks DTK; Byers L; Buckley D; Byron ZC; Chilvers RG; Cochrane L; Cooney E; Damian HA; Francis L; Fu He D; Grace JMJ; Green HJ; Hogarth EJP; Jusu L; Killalea CE; King O; Lambert J; Lee ZJ; Lima NS; Long CL; Mackinnon ML; Mahdy S; Matthews-Wright J; Millward MJ; Meehan MF; Merrett C; Morrison L; Parke HRI; Payne C; Payne L; Pike C; Seal A; Senior AJ; Smith KM; Stanelyte K; Stillibrand J; Szpara R; Taday FFH; Threadgould AM; Trainor RJ; Waters J; Williams O; Wong CKW; Wood K; Barton N; Gruszka A; Henley Z; Rowedder JE; Cookson R; Jones KL; Nadin A; Smith IE; Macdonald SJF; Nortcliffe A
J Med Chem; 2019 Nov; 62(22):10402-10422. PubMed ID: 31647659
[TBL] [Abstract][Full Text] [Related]
15. Effect and mechanism of ligustrazine on Th1/Th2 cytokines in a rat asthma model.
Xiong L; Fang ZY; Tao XN; Bai M; Feng G
Am J Chin Med; 2007; 35(6):1011-20. PubMed ID: 18186587
[TBL] [Abstract][Full Text] [Related]
16. High dose vitamin C supplementation increases the Th1/Th2 cytokine secretion ratio, but decreases eosinophilic infiltration in bronchoalveolar lavage fluid of ovalbumin-sensitized and challenged mice.
Chang HH; Chen CS; Lin JY
J Agric Food Chem; 2009 Nov; 57(21):10471-6. PubMed ID: 19831405
[TBL] [Abstract][Full Text] [Related]
17. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice.
Kato Y; Manabe T; Tanaka Y; Mochizuki H
J Immunol; 1999 Jun; 162(12):7470-9. PubMed ID: 10358202
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis.
Fan Y; Piao CH; Hyeon E; Jung SY; Eom JE; Shin HS; Song CH; Chai OH
Int Immunopharmacol; 2019 May; 70():512-519. PubMed ID: 30884431
[TBL] [Abstract][Full Text] [Related]
19. Rosae multiflorae fructus extract and its four active components alleviate ovalbumin-induced allergic inflammatory responses via regulation of Th1/Th2 imbalance in BALB/c rhinitis mice.
Bui TT; Kwon DA; Choi DW; Jung SY; Lee SY; Piao CH; Hyeon E; Fan Y; Yeon SH; Son RH; Shon DH; Song CH; Shin HS; Chai OH
Phytomedicine; 2019 Mar; 55():238-248. PubMed ID: 30668435
[TBL] [Abstract][Full Text] [Related]
20. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
